Search Results 2171-2180 of 40323 for Two-phase

  1. A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    ... phase 2 dose (RP2D) of APG-2575. Participation eligibility. Participant ... two months or doubling time in less than 6 months; enlarging adenopathy or ...

  2. Autism spectrum disorder - Diagnosis and treatment - Mayo Clinic

    Diagnosis. Your child's healthcare professional looks for signs of developmental delays at regular well-child checkups. If your child shows any symptoms of ...

  3. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. A Study To Assess FLX-787 In Subjects With Motor Neuron Disease Experiencing Muscle Cramps - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    Overview. Tab Title Description. Study typeInterventional Study phase2. Study ... ORV-PF-01 is a two way, placebo controlled, cross-over study, to evaluate the ...

  6. ​Gleason score grading for prostate cancer - Mayo Clinic

    The pathologists find the two most common patterns of cancer cells in the ... Cancer stages range from 1 to 4. A stage with a lower number typically ...

  7. A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Proton Therapy Clinical Trials - Mayo Clinic Research

    This study is being done to study which dose of proton beam therapy (PBT) for unresectable stage 2/3 Non-Small Cell Lung Cancer. survey with parents of ...

  9. A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) Participants - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...